JulieEManginoMD

Professor of Medicine, Ohio State University

Dr. Mangino is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1581 Dodd Dr
4th Floor
Columbus, OH 43210
Phone+1 614-293-4854

Fax+1 614-293-8102

I am board certified in Infectious Diseases working at The Ohio State University in Columbus, Ohio for the last 30 years. I started as an Assistant Professor until 2000, Associate Professor until 2010 and full Professor until my semi-retirement in 2018. I am the former Medical Director of Clinical Epidemiology with a focus on preventing healthcare associated infections and employing antimicrobial stewardship in a multitude of settings. I enjoy teaching ID Fellows, seeing patients and being involved in research to prevent infections for both the ambulatory and inpatient settings.

University of Alabama Medical CenterFellowship, Infectious Disease, 1992 - 1995
University of Alabama Medical CenterResidency, Internal Medicine, 1990 - 1992
Virginia Commonwealth University Health SystemInternship, Internal Medicine, 1989 - 1990
State University of New York Downstate Medical Center College of MedicineClass of 1989

Best Doctors 2005-2020
Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

PubMed

586 citations
A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.
Peter G. Pappas, John H. Rex, Jeannette Y. Lee, Richard J. Hamill, Robert A. Larsen
Clinical Infectious Diseases. 2003-09-01
64 citations
Hospital-Onset Clostridium difficile Infection Rates in Persons with Cancer or Hematopoietic Stem Cell Transplant: A C3IC Network Report
Mini Kamboj, Crystal Son, Sherry Cantu, Roy R Chemaly, Jeanne Dickman
Infection Control and Hospital Epidemiology. 2012-09-24
74 citations
Reactivation of histoplasmosis after treatment with infliximab.
Masha Nakelchik, Julie E. Mangino
The American Journal of Medicine. 2002-01-01

Journal Articles

Mangino JE, Firstenberg MS, Milewski RKC, Rhys-Williams W, Lees JP, Dane A, Love WG and Moreno JG. Exeporfinium Chloride (XF-73) Nasal Gel Dosed over 24 Hours prior to...
Mangino JE et al, Infection Control and Hospital Epidemiology, 3/23/2023

Nasal Gel Dosed Before Cardiac Surgery Reduced S. Aureus Burden vs. PlaceboMarch 30th, 2023
Wexner Medical Center Post-COVID-19 Recovery Program Treats Long-Haul PatientsNovember 18th, 2021
Proactive Headlines: Open Orphan, Bidstack, Evgen Pharma…July 9th, 2021
Join now to see all